A Phase II Trial Of BEAM/Rituximab/Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Patients With CD20 Positive Non-Hodgkin's Lymphoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rituximab (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan
- Indications B-cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 24 Jan 2018 Biomarkers information updated
- 18 Apr 2013 Planned End Date 1 Jan 2015 added as reported by ClinicalTrials.gov.
- 18 Apr 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.